OxyContin maker Purdue Pharma set to dissolve after judge approves sentence
Purdue Pharma, the maker of OxyContin, has been sentenced to dissolve after a federal judge ordered the company to pay over $5 billion in criminal penalties. The sentencing concludes the Department of Justice's criminal fraud case against the company, which pleaded guilty to charges in 2020. Purdue Pharma's dissolution will pave the way for Knoa Pharma to take its place, focusing on addressing the opioid crisis.
- ▪Purdue Pharma has been ordered to pay over $5 billion in criminal penalties.
- ▪The company will dissolve as part of the sentencing, which concludes the DOJ's case against it.
- ▪The Sackler family, owners of Purdue Pharma, must contribute $6.5 billion to settlement payments for opioid-related lawsuits.
2 outlets in our directory ran this story, first to last over 5 hours.
Washington Examiner files mainly under politics. We currently carry 2,275 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Washington Examiner |
| Canonical URL | https://www.washingtonexaminer.com/news/justice/4547143/oxycontin-purdue-pharma-dissolve-settlement/ |
| Publication time | Wed, 29 Apr 2026 03:25:37 +0000 |
| Retrieval time | 2026-04-29T04:00:09.686Z |
| Last seen | 2026-04-29T04:00:09.686Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | aDvUykWgvm74 · 2 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
A federal judge sentenced OxyContin manufacturer Purdue Pharma on Tuesday, ordering the company to pay over $5 billion in criminal penalties. The pharmaceutical company will soon dissolve, as the sentencing was the last step before Purdue Pharma had to legally move to close. The company will be replaced by Knoa Pharma, a company aimed at providing relief to and addressing the opioid crisis. The sentencing marks an end to the Department of Justice’s criminal fraud case against Purdue Pharma.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Washington Examiner.
Discussion
0 commentsMore from Washington Examiner
